Search

You searched for "lesions"

2233 results found
Auris Nasus Larynx journal cover image.

Effects of diet and exercise on tinnitus

4 May 2023 | | ENTA - Audiology - Adult, ENTA - Tinnitus, ENTA - Otology
Subjective tinnitus is the perception of sound without any external stimulus. There is no consensus on the aetiology of tinnitus. Obesity is one condition that has been associated with subjective tinnitus. The authors conducted a randomised controlled trial to assess...
Dysphagia journal cover image.

Measuring radiation fibrosis in patients with head and neck cancer

4 March 2025 | | ENTA - Laryngology / Swallowing / Voice
People treated with radiotherapy for head and neck cancer experience several acute and chronic effects of this treatment, of which fibrosis is perhaps the most common. Fibrosis occurs as a wound healing response and leads to scarring and reduced range...
Laryngology & Otology journal cover image.

Association of tinnitus with dementia

2 May 2025 | | ENTA - Otology
In this large case-controlled study, the authors have compared the presence of tinnitus prior to the diagnosis of dementia in the study group with those without dementia. Dementia patients were selected from the National Health Insurance group. The control group...

Puma seeks new collaborations in key European countries and worldwide

22 September 2022 | Company Profiles, Contracts & Distributors
Puma Soundproofing exports 60% of its turnover – currently over 5,000 booths have been successfully installed in hospitals, clinics and universities across more than 50 countries worldwide.

FDA grants Lenire tinnitus treatment device De Novo approval

15 March 2023 | Company Profiles, Research & Development
Neuromod Devices Ltd. is proud to announce that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire.

Genetic foundations of Ménière’s disease: changing the game

4 November 2025 | | ENTA - Vestibular Disorders, ENTA - Neurotology, ENTA - Audiology - Diagnostic, ENTA - Tinnitus
Sydney researchers reveal genetic roots of Ménière’s disease. Familial patterns and gene discoveries highlight autosomal inheritance in rare cases, transforming molecular insights. Ménière’s disease (MD) is a chronic disorder of the inner ear defined by clinical criteria of episodic vertigo...

Developing outcome measures for research

1 January 2018 | | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic
There are challenges in developing outcomes measures; Professor Hall presents five top pointers for making rapid progress in developing outcome measures for research purposes. Anyone who has worked clinically with hearing loss will appreciate that every patient’s experience is personal....

Victoria Possamai, Consultant Paediatric ENT Surgeon - A Tribute

8 April 2025 | | ENTA - General
Victoria Possamai, Consultant Paediatric ENT Surgeon, Evelina London Children’s Hospital. 30 August 1977 – 6 December 2024 It is with great sadness that we reflect on the loss of our wonderful colleague and friend Victoria ‘Vikki’ Possamai, Consultant Paediatric ENT...

Landmark clinical trial into treatment for severe hearing loss launches

3 January 2022
Researchers at the NIHR Nottingham Biomedical Research Centre and the University of Nottingham are launching a new study, sponsored by the University of Nottingham, which will inform the most effective treatment for people with severe hearing loss globally (those with...

Celebrating CIICA's first anniversary

1 March 2022
It was cause for a double celebration: not only was 25 February named as International Cochlear Implant Day, but it was the first anniversary of the CI International Community of Action (CIICA).

Independent lab tests and rates hearing aids

5 February 2023
HearAdvisor is a new audio testing lab designed to understand how the performance of hearing aids differs.

Doctors urged to treat patients with sudden hearing loss within seven days

20 November 2024
A team of clinician scientists have identified the factors that predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.